OB/GYN Clinical Alert
RSSArticles
-
Concomitant Hysteroscopic Sterilization and Endometrial Ablation: What Are the Risks?
In this retrospective cohort study, women who underwent concomitant hysteroscopic sterilization and endometrial ablation procedures were more likely to have inadequate 3-month hysterosalpingram testing to confirm tubal occlusion.
-
Are We on the Threshold of a New Approach to Evaluating Women with Recurrent Pregnancy Loss?
A small retrospective cohort study raises the possibility that advanced genetic techniques can be used to analyze the products of conception in women with recurrent pregnancy loss to identify those most likely to have treatable reasons for their miscarriages.
-
Induction of Labor in Patients with Previous Cesarean Sections
ABSTRACT & COMMENTARY: Great improvements have been made while the fear of litigation ebbs.
-
Morcellation: Has it Improved Outcomes or Put Women at Risk?
Widespread concern over malignant tumor dissemination with morcellation threatens to undermine advances in minimally invasive gynecologic surgery that have benefited women. Before providers abandon this technique, they should put the risks and benefits in perspective.
-
Can Cerebroplacental Ratio Predict Neonatal Mortality?
Recent articles show the cerebroplacental ratio to be a useful predictor of immediate and later neonatal morbidity, particularly, in late-onset intrauterine growth restriction.
-
Quality of Information on Pelvic Organ Prolapse on the Internet
After review of more than 400 websites, most web-based information available to women regarding pelvic organ prolapse treatment is incomplete. The best-quality information was found on government-sponsored websites.
-
Flibanserin: A Billion Dollar Market?
On the third attempt, the FDA approved the treatment for generalized hypoactive sexual desire disorder in premenopausal women.
-
Environmental Influences on Male Reproductive Function
This special feature is intended to provide readers with information needed about the potential impact of the environment and lifestyle on male reproductive function so that they can better take histories and counsel couples presenting with questions about infertility.
-
When Do Combined Oral Contraceptives Start Working After Ulipristal Acetate Emergency Contraception?
In this randomized, controlled trial of the effects of combined oral contraceptives on ovarian activity after taking ulipristal acetate, investigators found that some women needed up to 14 days to achieve ovarian quiescence. Therefore, abstinence or backup contraception should be used during that time.
-
Good News for a Change: No Association of Hormonal Replacement Therapy with Breast Cancer Before Age 50
Using data from the Two Sister Study, investigators found no association of past combined hormone replacement therapy with young-onset (before age 50) breast cancer, and a protective effect with estrogen-only therapy.